Leishmaniasis vaccination: targeting the source of infection.

about

The future of vaccination as a treatment strategy in dermatological diseases.Leishmania major chromosome 3 contains two long convergent polycistronic gene clusters separated by a tRNA gene

P2860

Q35015879-4837CDD7-7203-4D07-8343-3619B27AB7E6 Q35186026-23713CAB-F56F-443A-A00F-043F08C6D4E3

P2860

Leishmaniasis vaccination: targeting the source of infection.

Item

http://www.wikidata.org/entity/Q42944456

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

2001年论文

@zh

2001年论文

@zh-cn

name

Leishmaniasis vaccination: targeting the source of infection.

@en

Leishmaniasis vaccination: targeting the source of infection.

@nl

type

Item

label

Leishmaniasis vaccination: targeting the source of infection.

@en

Leishmaniasis vaccination: targeting the source of infection.

@nl

prefLabel

Leishmaniasis vaccination: targeting the source of infection.

@en

Leishmaniasis vaccination: targeting the source of infection.

@nl

P1476

Leishmaniasis vaccination: targeting the source of infection.

@en

P2093

Reed SG

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin 10 production correlates with pathology in human Leishmania donovani infections

The delayed hypersensitivity induced by antigen-antibody complexes.

Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein.

Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis.

Variation in the salivary peptide, maxadilan, from species in the Lutzomyia longipalpis complex.

Histological Studies of Hypersensitive Reactions.

The regulation of immunity to Leishmania major.

T-cell and cytokine responses in leishmaniasis.

Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. III. Inhibition of leishmanial lesion in the guinea-pig by delayed hypersensitivity reaction to unrelated antigens.

Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.

P304

F7-F9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

editorial

P356

10.1084/JEM.194.3.F7

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

194

http://www.w3.org/2001/XMLSchema#string

P577

2001-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2001-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11489957

http://www.w3.org/2001/XMLSchema#string

P921

leishmaniasis

preventive health services

biomedical investigative technique

P932

2193470

http://www.w3.org/2001/XMLSchema#string

Leishmaniasis vaccination: targeting the source of infection.

about

P2860

P2860

Leishmaniasis vaccination: targeting the source of infection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932